Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,140
Closed -$279K 842
2021
Q2
$279K Sell
1,140
-51
-4% -$13.4K 0.03% 701
2021
Q1
$321K Sell
1,191
-77
-6% -$21.7K 0.03% 656
2020
Q4
$372K Sell
1,268
-20
-2% -$5.13K 0.04% 523
2020
Q3
$305K Sell
1,288
-11
-0.8% -$2.5K 0.03% 540
2020
Q2
$258K Buy
1,299
+16
+1% +$2.98K 0.03% 598
2020
Q1
$235K Sell
1,283
-32
-2% -$5.69K 0.02% 695
2019
Q4
$219K Buy
+1,315
New +$196K 0.01% 945

Other funds holding AMED

World Asset Management's AMED Position: Q3 2021 in Review

World Asset Management sold out of Amedisys (AMED) in Q3 2021, closing a stake of 1,140 shares — an estimated $279K sold.

World Asset Management first reported a position in AMED in Q4 2019 and held it in 7 quarters. The position peaked at $372K in Q4 2020. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • World Asset Management reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • World Asset Management sold 1,140 Amedisys shares in Q3 2021, an estimated $279K.
  • World Asset Management first reported a position in Amedisys in Q4 2019 and held it in 7 quarters.
  • World Asset Management's Amedisys position peaked at $372K in Q4 2020.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.